Champions Oncology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Champions Oncology stock has a target of 8.00, which predicts an increase of 6.60% from the current stock price of 7.51.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$8.00	$8.00	$8.00
Change	+6.60%	+6.60%	+6.60%	+6.60%

Analyst Ratings

According to 1 stock analyst, the rating for CSBR is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	2	2	2	1
Buy	0	0	0	0	0	0
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $6 → $8	Strong Buy	Maintains	$6 → $8	+6.60%	Dec 12, 2024
Matt Hewitt Craig-Hallum	Craig-Hallum	Hold → Strong Buy Upgrades $6	Hold → Strong Buy	Upgrades	$6	-20.05%	Sep 12, 2024
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 13, 2024
Scott Henry Roth MKM	Roth MKM	Strong Buy Maintains $9 → $7.5	Strong Buy	Maintains	$9 → $7.5	-0.07%	Sep 22, 2023
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $14 → $16	Strong Buy	Maintains	$14 → $16	+113.19%	Mar 15, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

57.27M

from 50.16M

14.19%

from 50.16M

Revenue Next Year

63.06M

from 57.27M

10.11%

from 57.27M

EPS This Year

0.21

from -0.54

EPS Next Year

0.24

from 0.21

14.29%

from 0.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 30, 2020	Apr 30, 2021	Apr 30, 2022	Apr 30, 2023	Apr 30, 2024	Apr 30, 2025	Apr 30, 2026	Apr 30, 2027
Revenue	32.12M	41.04M	49.11M	53.87M	50.16M	57.27M	63.06M	81.64M
Revenue Growth	18.68%	27.76%	19.66%	9.69%	-6.90%	14.19%	10.11%	29.46%
EPS	-0.18	0.02	0.04	-0.39	-0.54	0.21	0.24	-
EPS Growth	-	-	100.01%	-	-	-	14.29%	-
Forward PE	-	-	-	-	-	35.04	30.66	-
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	59.0M	64.9M	84.0M
Avg	57.3M	63.1M	81.6M
Low	55.0M	60.6M	78.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	17.6%	13.3%	33.3%
Avg	14.2%	10.1%	29.5%
Low	9.7%	5.8%	24.4%

EPS Forecast

EPS	2025	2026
High	0.22	0.25
Avg	0.21	0.24
Low	0.21	0.24

EPS Growth

EPS Growth	2025	2026
High	-	17.6%
Avg	-	14.3%
Low	-	9.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.